Perrigo | PRGO - Selling And Administration Expenses

Stock Price
14.97
Daily Change
0.08 0.54%
Monthly
-0.80%
Yearly
-37.97%
Q1 Forecast
14.00

Perrigo reported $245.7M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
AbbVie USD 3.89B 325M Dec/2025
Abbott USD 3.13B 125M Dec/2025
Bayer EUR 3.4B 140M Sep/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Coherus Biosciences USD 26.02M 8.57M Mar/2025
Corcept Therapeutics USD 106.97M 3.12M Sep/2025
Dr.Reddys Laboratories INR 26.92B 482M Dec/2025
Eli Lilly USD 3.13B 391.3M Dec/2025
J&J USD 6.75B 831M Dec/2025
Merck USD 2.85B 215M Dec/2025
Nestle CHF 12.73B 181M Jun/2025
Pacira USD 91.8M 14.6M Sep/2025
Perrigo USD 245.7M 27.4M Sep/2025
Pfizer USD 4.08B 894M Dec/2025
Phibro Animal Health USD 76.34M 10.54M Dec/2024
Prestige Brands USD 29.67M 1.64M Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
Supernus Pharmaceuticals USD 179.68M 117.46M Sep/2025
Teva Pharmaceutical Industries USD 1.12B 147M Dec/2025
Xeris Pharmaceuticals USD 46.46M 2.07M Sep/2025
Zoetis USD 619M 40M Dec/2025